Onkologie. 2024:18(3):216-218 | DOI: 10.36290/xon.2024.041

Individualised therapy for patient with prostatic cancer

Adam Lukáč
Onkologická klinika, 2. LF a FN Motol, Praha

The age of precision and personalized oncology is now, but application of new therapeutic possibilities and new pharmaceuticals brings new challenges. In most cases, patients with malignant tumors are of older age with chronic diseases, which complicate usage of new pharmaceuticals or their combination. In this clinical case, we would like to present treatment challenges on a patient with hepatic transplantation, who was diagnosed with prostate carcinoma.

Keywords: prostatic cancer, transplantation, hepatic functional reserve, overdose, tacrolimus, cytochrome CYP3A4.

Accepted: June 18, 2024; Published: June 24, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lukáč A. Individualised therapy for patient with prostatic cancer. Onkologie. 2024;18(3):216-218. doi: 10.36290/xon.2024.041.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Koordinační středisko transplantací. Webové sídlo. Available from: https://kst.cz/statistiky/.
    2. Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306:1891. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.